Spruce Biosciences, Inc. Increase (Decrease) in Other Operating Liabilities
Spruce Biosciences, Inc. (SPRB) reported Increase (Decrease) in Other Operating Liabilities of -$174.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-12
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$87.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$87.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $201.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$80.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was -$317.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was -$237.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$176.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$331.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$174.00K 10-Q · filed 2026-08-12 | $27.00K derived: sum of 3 quarters · filed 2026-08-12 | -$53.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$87.00K 10-Q · filed 2026-05-13 | $114.00K derived: sum of 2 quarters · filed 2026-05-13 | $34.00K derived: sum of 3 quarters · filed 2026-05-13 | -$45.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $121.00K derived: sum of 2 quarters · filed 2026-03-09 | $42.00K derived: sum of 3 quarters · filed 2026-08-12 | -$317.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$159.00K derived: sum of 2 quarters · filed 2026-08-12 | -$518.00K 10-Q · filed 2025-11-10 | -$582.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$438.00K 10-Q · filed 2026-08-12 | -$502.00K derived: sum of 3 quarters · filed 2026-08-12 | -$562.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$359.00K 10-Q · filed 2026-05-13 | -$423.00K derived: sum of 2 quarters · filed 2026-05-13 | -$483.00K derived: sum of 3 quarters · filed 2026-05-13 | -$541.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$124.00K derived: sum of 2 quarters · filed 2026-03-09 | -$182.00K derived: sum of 3 quarters · filed 2026-03-09 | -$237.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$118.00K derived: sum of 2 quarters · filed 2025-11-10 | -$173.00K 10-Q · filed 2025-11-10 | -$221.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$113.00K 10-Q · filed 2025-08-14 | -$161.00K derived: sum of 3 quarters · filed 2025-08-14 | -$207.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$55.00K 10-Q · filed 2025-05-06 | -$103.00K derived: sum of 2 quarters · filed 2025-05-06 | -$149.00K derived: sum of 3 quarters · filed 2025-05-06 | -$190.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$94.00K derived: sum of 2 quarters · filed 2025-04-15 | -$135.00K derived: sum of 3 quarters · filed 2025-04-15 | -$176.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$87.00K derived: sum of 2 quarters · filed 2024-11-12 | -$128.00K 10-Q · filed 2024-11-12 | -$230.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$82.00K 10-Q · filed 2024-08-12 | -$184.00K derived: sum of 3 quarters · filed 2024-08-12 | -$282.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$41.00K 10-Q · filed 2024-05-13 | -$143.00K derived: sum of 2 quarters · filed 2024-05-13 | -$241.00K derived: sum of 3 quarters · filed 2024-05-13 | -$307.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$200.00K derived: sum of 2 quarters · filed 2024-03-18 | -$266.00K derived: sum of 3 quarters · filed 2024-03-18 | -$331.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | -$98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$164.00K derived: sum of 2 quarters · filed 2023-11-13 | -$229.00K 10-Q · filed 2023-11-13 | -$291.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$131.00K 10-Q · filed 2023-08-14 | -$193.00K derived: sum of 3 quarters · filed 2023-08-14 | -$253.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$65.00K 10-Q · filed 2023-05-15 | -$127.00K derived: sum of 2 quarters · filed 2023-05-15 | -$187.00K derived: sum of 3 quarters · filed 2023-05-15 | -$244.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$122.00K derived: sum of 2 quarters · filed 2022-11-10 | -$179.00K derived: sum of 3 quarters · filed 2022-11-10 | -$156.00K 10-K · filed 2022-03-14 |
| 2021-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$117.00K derived: sum of 2 quarters · filed 2022-11-10 | -$94.00K 10-Q · filed 2022-11-10 | -$38.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$34.00K 10-Q · filed 2022-08-10 | $22.00K derived: sum of 3 quarters · filed 2022-08-10 | $40.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $23.00K 10-Q · filed 2022-05-11 | $79.00K derived: sum of 2 quarters · filed 2022-05-11 | $97.00K derived: sum of 3 quarters · filed 2022-05-11 | $124.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $74.00K derived: sum of 2 quarters · filed 2022-03-14 | $101.00K derived: sum of 3 quarters · filed 2022-03-14 | $142.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $45.00K derived: sum of 2 quarters · filed 2021-11-15 | $86.00K 10-Q · filed 2021-11-15 | $103.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $68.00K 10-Q · filed 2021-08-10 | $85.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $41.00K 10-Q · filed 2021-05-12 | $58.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $20.00K 10-K · filed 2021-03-22 | ||
| 2019-09-30 | $3.00K 10-Q · filed 2020-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |